Flecainide is well-tolerated and effective in patient with atrial fibrillation at 12 months: a retrospective study

Abstract

Flecainide is a well-tolerated medication, even at 12 months, with very minor adverse effects. These results support the utility of flecainide in guideline recommended patient populations.